Deep Track Capital, LP Gritstone Bio, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.46 - $4.75 $4.12 Million - $7.95 Million	-1,674,500 Reduced 97.35%	45,500 $117,000
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $2.24 Million - $5.49 Million	-1,265,729 Reduced 42.39%	1,720,000 $4.16 Million
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $4.89 Million - $14.8 Million	1,213,928 Added 68.51%	2,985,729 $12.3 Million
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $15.5 Million - $24.3 Million	1,771,801 New	1,771,801 $22.8 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.